<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cytogenetic studies can be useful in the clinical management of patients with <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>They may also give a clue to <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> and/or pathogenesis </plain></SENT>
<SENT sid="2" pm="."><plain>Numerous disease-specific chromosomal aberrations have been and continue to be identified </plain></SENT>
<SENT sid="3" pm="."><plain>Translocation (1;19)(q21 through q23;p13.3) involving the long arm of chromosome 1 and the short arm of chromosome 19 is usually associated with <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>We found a new translocation involving one virtually identical breakpoint 19p13 and one distinct 1p13 in two cases of myeloid <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Studies of bone marrow and peripheral blood specimens specified in one of our patients <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> and in an other <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Conventional cytogenetics was supplemented by spectral karyotyping (SKY), microdissection, and fluorescence in situ hybridization </plain></SENT>
<SENT sid="7" pm="."><plain>Our first case showed a der(1)t(1;19)(p13;p13.1) as the sole chromosomal change </plain></SENT>
<SENT sid="8" pm="."><plain>In addition to this translocation, a pericentric inversion within chromosome 10 and with a cryptic t(10;11) were detected by SKY in the second case </plain></SENT>
<SENT sid="9" pm="."><plain>Translocation (1;19)(p13;p13.1) may play a role in the <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> of myeloid diseases </plain></SENT>
</text></document>